Who owns BIOAFFINITY TECHNOLOGIES INC?
- Ticker: BIAF
- CUSIP Number: 09076w109
Tip: Access positions for across all investors
Analyze quarterly positions in Bioaffinity Technologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Bioaffinity Technologies stock
Who bought or sold BIOAFFINITY TECHNOLOGIES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 70k | $142k | 252% | Mar 2024 |
|
Geode Capital Management | 42k | $85k | 100% | Mar 2024 |
|
Captrust Financial Advisors | 28k | $56k | -30% | Mar 2024 |
|
Northern Trust | 14k | $28k | 100% | Mar 2024 |
|
Creative Planning | 12k | $24k | 0% | Mar 2024 |
|
IFP Advisors | 5.0k | $7.4k | 100% | Dec 2023 |
|
Tower Research Capital | 3.3k | $6.8k | -17% | Mar 2024 |
|
Clear Street | 100.00 | $0 | 100% | Mar 2024 |
|
Wells Fargo & Company | 45.00 | $90.999000 | 10% | Mar 2024 |
|
Qube Research & Technologies | 38.00 | $76.999400 | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 13.00 | $26.000000 | 44% | Mar 2024 |
|
Who sold out of Bioaffinity Technologies?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Two Sigma Investments | Dec 2023 | 22k | $32k |